External medicament for treating tinea manuum and tinea pedis

A technology of tinea manus and pedis and medicament, which is applied in the field of external medicaments for treating tinea manuum and pedis, can solve the problems of toxic and side effects, long medication cycle, heavy economic burden, etc., and achieve the effect of small molecular size, avoiding toxic and side effects, and rapid soaking and washing effect

Inactive Publication Date: 2018-05-01
安徽世龙生物医药科技有限公司
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long medication cycle, toxic and side effects on liver and kidney, heavy economic burden

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External medicament for treating tinea manuum and tinea pedis
  • External medicament for treating tinea manuum and tinea pedis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] 1. Preparation of A effervescent tablet

[0041] Weigh the bulk drug according to the following weight (unit: g)

[0042] Sophora flavescens extract 1000g, salicylic acid 2000g, benzoic acid 1000g, mugwort leaf oil 10g, sodium bicarbonate 450g, sodium carbonate 50g, lactose 400g, polyethylene glycol (6000) 90g.

[0043] Weigh the raw materials and auxiliary materials (except Artemisia argyi) according to the prescription, crush them into fine powder (through a 100-mesh sieve), add Artemisia argyi oil, mix well, dry granulate, pass through a 20-mesh sieve for granulation, and tablet (specification 5g / tablet) ), make a total of 1000 tablets, and get it.

[0044] 2. Preparation of B gel

[0045] Weigh the bulk drug according to the following weight (unit: g)

[0046] Clove basil oil 12.5g, cinnamon oil 7.5g, litsea cubeba oil 10g, salicylic acid 10g, undecylenic acid 15g, peppermint oil 5g, glycerin 80g, carbo (940) 25g, laurocaprolactone 20g, polysorbate Alcohol ester (...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an external medicament for treating tinea manuum and tinea pedis. The external medicament consists of an effervescent tablet A and a gel B, and the main ingredients comprise clove basil oil, cinnamon oil, litsea cubeba oil, eucalyptus oil, a light yellow sophora root extract, salicylic acid, undecylenic acid and the like; and the external medicament has the functions of clearing away heat and toxic materials, killing bacteria, diminishing inflammation, drying dampness and killing insects. The medicament provided by the invention is different from a treatment scheme in the past for treating tinea manuum and tinea pedis only, firstly, the effervescent tablet A is used to quickly kill pathogenic bacteria on the surface of skin to keep the skin clean and environment, and achieve an effect of no recurrence by forcibly killing the bacteria. An epidermal tissue structure of the surface layer infected by diseases, so that a thickened and keratinized skin structure becomes loose to form a channel conducive to smooth penetration of the medicament; on the premise of dredging the channel of medicament penetration, the gel B is used to quickly and thoroughly remove and kill the pathogenic bacteria in the skin; and the combination of the two agents is multi-layered and three-dimensional, achieves both prevention and treatment of symptoms and root causes, and the treatment method is unique and the curative effect is reliable.

Description

technical field [0001] The invention relates to an external medicament for treating tinea manus and pedis. Background technique [0002] Tinea manuum and tinea pedis are dermatophyte infections that occur between palms, soles of the feet, and fingers (toes), and can also affect hands, dorsums of feet, wrists, and ankles. According to the site of disease, can be divided into tinea manuum and tinea pedis again. Tinea manuum is commonly called as " goose palm wind ", and tinea pedis is commonly called as " athlete's foot ". The sickness rate of tinea pedis is far higher than that of tinea manuum, and it is particularly common in southern my country. [0003] At present, the chemical medicine preparations (including external and oral preparations) for the treatment of tinea pedis class superficial fungal diseases at home and abroad mainly include salicylic acids; undecylenic acids such as zinc undecylenate, azoles such as ketoconazole, Conazole, miconazole, triazoles such as ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/54A61P17/00A61P31/10A61K31/192A61K31/60
CPCA61K36/489A61K9/0014A61K31/192A61K31/60A61K36/282A61K36/53A61K36/534A61K36/54A61K47/10A61K47/22A61K47/26A61K2300/00
Inventor 汪世龙
Owner 安徽世龙生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap